Press Releases April 6, 2026

Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026

Nanox announces Q4 2025 financial results release and conference call scheduled for April 20, 2026

By Sofia Navarro NNOX
Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026
NNOX

Nanox Imaging Ltd, a Nasdaq-listed medical imaging technology company, will report its Q4 2025 financial results on April 20, 2026, followed by a conference call featuring senior executives. The company focuses on integrating affordable imaging hardware with AI, cloud solutions, and remote radiology to improve preventive healthcare.

Key Points

  • Nanox will report Q4 2025 financial results before market open on April 20, 2026.
  • The company integrates digital X-ray technology, AI-based analysis, cloud infrastructure, and tele-radiology services, aimed at expanding preventive healthcare access.
  • Nanox's product ecosystem includes Nanox.ARC 3D tomosynthesis imaging, AI algorithms for CT image interpretation, cloud data management, and remote radiology marketplace.

PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended December 31, 2025, before market open on Monday, April 20, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link: Nanox Q4 2025 Call

The live webcast of the conference call may be accessed by using the following link: Nanox Q4 2025 Webcast.

The webcast link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations. 

About Nanox

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.

Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.

Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.

The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. For more information, please visit www.nanox.vision

Contacts

Investor Contact
Mike Cavanaugh
ICR Healthcare
[email protected]

Media Contact
ICR Healthcare
[email protected]


Risks

  • Execution risk related to commercial adoption and scaling of its integrated imaging and AI platform.
  • Regulatory and technological risks associated with deploying new medical imaging devices and AI diagnostics.
  • Market acceptance and competition risks in the healthcare imaging and telemedicine sectors.

More from Press Releases

Cloudastructure to Participate in “Powering the AI Revolution” Virtual Conference Presented by Maxim Group LLC on Tuesday, April 7th at 9:00 a.m. EDT Apr 6, 2026 Apogee Acquisition Corp Announces Pricing of $150 Million Initial Public Offering Apr 6, 2026 OFA Group Strengthens Balance Sheet and Long-Term Earnings Profile Through Strategic IP Ownership Realignment Apr 6, 2026 Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy Apr 6, 2026 PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of Second Fiscal Quarter 2026 Results Apr 6, 2026